C3i Center Inc is Canada's premier contract development and manufacturing organisation (CDMO) specialising in cell and gene therapies.

Established to bridge the gap between groundbreaking research and patient-ready treatments, C3i Center Inc has become a pivotal entity in the biotechnology sector. With over 15 years of expertise in cell therapy and current Good Manufacturing Practice (cGMP) manufacturing, the organisation collaborates closely with clients to produce advanced cell and gene products that comply with global regulatory standards. C3i's fully validated cGMP facility in Canada is uniquely compliant with the regulations of the FDA, EMA, and Health Canada, offering commercial-scale manufacturing capabilities. The centre is driven by a commitment to patient welfare, recognising that the therapies they develop often represent a patient's best hope for recovery.

Key products and services:

• Manufacturing: Comprehensive services ranging from process development to commercial-scale production of cell and gene therapies.
• Laboratory Services: Expertise in assay development, qualification, validation, and quality control to ensure the highest standards of product testing.
• Clinical Research: A full spectrum of services supporting cell and gene therapy-based clinical trials, facilitating the transition from research to clinical application.
• Consultation Services: Strategic guidance and support to navigate the complexities of bringing cell and gene therapies to market.

C3i Center Inc stands at the forefront of the cell and gene therapy revolution, dedicated to transforming innovative research into life-saving treatments. By fostering close partnerships and maintaining an unwavering focus on quality and compliance, C3i continues to advance the biotechnology landscape, offering hope and healing to patients worldwide.